Adagio Medical Holdings (ADGM) Long-Term Debt Issuances (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Long-Term Debt Issuances of $5.5 million for Q2 2024, down 45.0% sequentially from $10.0 million in Q1 2024.

Adagio Medical Holdings (ADGM) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Long-Term Debt Issuances data on file, last reported at $5.5 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	19.86 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	11.71 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	1.15 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Adagio Medical Holdings	21.49 Mn	21.49 Mn	-	-

Download Data